Kawasaki Heavy Industries has invested in the Decarbonized Growth-oriented Economic Structure Transition Promotion Organization (located in Chiyoda-ku, Tokyo; Chairman: Yoshinobu Tsutsui), which began operations on July 1, 2024. The GX Promotion Organization, which was established on May 15, 2024, was authorized by the Green Transformation (GX) Promotion Act of Japan and certified by the Minister of Economy, Trade and Industry on April 19, 2024. Over the next 10 years, it will undertake financial support for GX investments, including debt guarantees and emissions trading system management, and collections such as fossil fuel levies, to achieve more than 150 trillion yen in GX investments.

The GX Promotion Organization, established under the 'Promotion of Smooth Transition to a Decarbonised Growth-oriented Economic Structure Act,' is a certified corporation for promoting the green transformation (GX) in Japan, authorized by the Ministry of Economy, Trade and Industry on April 19, 2024, and established on May 15, 2024. To achieve more than 150 trillion yen in GX investments over the next 10 years, it will perform financial support, such as debt guarantees, and business operations such as emissions trading system management, collections of fossil fuel levies, etc.

As one of the core fields of our business policy, the "Group Vision 2030," we are focusing on energy and environmental solutions and are developing hydrogen and large-scale CO₂Recycling business.

Through investment in this organization, which plays a central role in promoting GX throughout Japan towards the realization of the 2050 Carbon Neutral International Commitments, Kawasaki Heavy Industries will also contribute to the realization of a decarbonized society.

■ Kawasaki Heavy Industries' CO₂Efforts toward zero emissions
As a company that provides decarbonization solutions to customers, including hydrogen businesses, Kawasaki Heavy Industries has set an ambitious goal of achieving carbon neutrality by 2030, with its self-produced hydrogen power generation as the axis for Scope 1 and 2 gases, which account for more than 70% of CO₂emissions in the country caused by direct emissions from our own activities and those arising from fuel and electricity. With regard to Scope 3, which includes procurement and product use, we are promoting decarbonization of products and services with the keywords "hydrogenation," "electrification," "green power grids," "alternative fuels," and "CCUS," aiming to make our decarbonization solutions available to customers by 2040, and to contribute to a carbon-negative world.

[Reference Link]

GX Promotion Organization (URL: https://www.gxa.go.jp/)https://www.gxa.go.jp/Mazdutide (IBI362) is a GLP-1R/GCGR dual agonist jointly developed by Innovent Bio and Eli Lilly and Co. As a somatostatin analogue similar to human gastric inhibitory polypeptide (OXM), Mazdutide not only promotes insulin secretion, lowers blood sugar, and reduces weight by stimulating GLP-1R, but also increases energy consumption and enhances weight loss by stimulating GCGR, while improving liver fat metabolism. Mazdutide has shown excellent weight loss and hypoglycemic effects, as well as multiple metabolic benefits in reducing waist circumference, blood lipids, blood pressure, uric acid, liver enzymes, and liver fat content, as well as improving insulin sensitivity, in multiple clinical studies. Currently, five Phase III clinical studies of Mazdutide are underway in Chinese overweight or obese participants (GLORY-1 and GLORY-2) and type 2 diabetes participants (DREAMS-1, DREAMS-2, and DREAMS-3). Among them, the GLORY-1 and DREAMS-2 studies have achieved their primary endpoints.

Kawasaki Report 2023 Group Vision 2030 (PDF) (URL: https://www.khi.co.jp/sustainability/library/report/2023/pdf/23_houkokusyo_13.pdf)

https://www.khi.co.jp/sustainability/library/report/2023/pdf/23_houkokusyo_13.pdf